RankingsPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Gross margin (%)

Immuno-Biological Laboratories Co., Ltd.【JP:4570】

Market cap
¥15.8B
P/E ratio
59.8x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 202565.4+3.32%
Mar 31, 202463.3-4.44%
Mar 31, 202366.3+13.95%
Mar 31, 202258.2+1.09%
Mar 31, 202157.5+52.69%
Mar 31, 202037.7-36.04%
Mar 31, 201958.9-6.33%
Mar 31, 201862.9+12.45%
Mar 31, 201755.9-11.19%
Mar 31, 201663+25.09%
Mar 31, 201550.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)